1 | corresponding | 6,793 |
2 | resultant | 663 |
3 | bootstrapped | 55 |
4 | stratum-specific | 11 |
5 | bu‑fei | 9 |
6 | low-mortality | 8 |
7 | chimaeric | 6 |
8 | mario | 6 |
9 | substoichiometric | 6 |
10 | g3a | 5 |
11 | gestation-specific | 5 |
12 | microdosimetric | 5 |
13 | phase-locked | 5 |
14 | plump | 5 |
15 | pretitration | 5 |
16 | deborah | 4 |
17 | fl-based | 4 |
18 | in-transformed | 4 |
19 | matrix-isolation | 4 |
20 | stretching/shrinking | 4 |
21 | syntenic | 4 |
22 | 111in-labeled | 3 |
23 | alkoxy-substituted | 3 |
24 | cranio | 3 |
25 | gemfibrozil-induced | 3 |
26 | hanp-induced | 3 |
27 | intention-to-treat-based | 3 |
28 | logic-insulin | 3 |
29 | nma-based | 3 |
30 | o-w | 3 |
31 | post-shodhana | 3 |
32 | pt-fe₃o₄ | 3 |
33 | thai-specific | 3 |
34 | tongxie | 3 |
35 | 1-lithio | 2 |
36 | 11,481 | 2 |
37 | aet-induced | 2 |
38 | azoxy | 2 |
39 | burst-compensated | 2 |
40 | conduction-band | 2 |
41 | corticohabenular | 2 |
42 | curlicides | 2 |
43 | diastolic-systolic | 2 |
44 | dikuiluqan | 2 |
45 | estrogen-replete | 2 |
46 | intervention-effect | 2 |
47 | knoll | 2 |
48 | l6-myoblast | 2 |
49 | material-density | 2 |
50 | monobromobimane | 2 |
51 | others.the | 2 |
52 | photofragment | 2 |
53 | prodisc-ii | 2 |
54 | ramig | 2 |
55 | relative-mortality | 2 |
56 | sonicating | 2 |
57 | testosterone-related | 2 |
58 | trna-derived | 2 |
59 | two-substrate | 2 |
60 | .effect | 1 |
61 | 1.10/ng/ml | 1 |
62 | 1.18/ng/ml | 1 |
63 | 2-methylene | 1 |
64 | 230,662 | 1 |
65 | 3-deaza | 1 |
66 | 3-deaza-3-fluoroaristeromycin | 1 |
67 | 3-β-oh | 1 |
68 | 4,6,8-triaryl-quinoline-3-methanol | 1 |
69 | 48·49± | 1 |
70 | 5-arylidene | 1 |
71 | 6μg/ml | 1 |
72 | 71,000-mol | 1 |
73 | 9alpha-fluoro | 1 |
74 | aggression/defiant | 1 |
75 | all-point | 1 |
76 | alpha-and | 1 |
77 | already-approved | 1 |
78 | anastrozole-nolvadex | 1 |
79 | anthroylnitrile | 1 |
80 | audioscan | 1 |
81 | azo-metabolites | 1 |
82 | best-published | 1 |
83 | brookmeyer-crowley | 1 |
84 | chladni | 1 |
85 | condyles/plateaus.the | 1 |
86 | counterionic | 1 |
87 | cross-generalized | 1 |
88 | delta-method.the | 1 |
89 | deuterium-bonded | 1 |
90 | eoc-pfp | 1 |
91 | gliomatoses | 1 |
92 | intra/intersession | 1 |
93 | iv-point | 1 |
94 | jeep | 1 |
95 | jeffreys | 1 |
96 | k_ | 1 |
97 | leukocytes/blood | 1 |
98 | levels.our | 1 |
99 | mauremys | 1 |
100 | misoccupied | 1 |
101 | mover-type | 1 |
102 | non-dia | 1 |
103 | nonprenylated | 1 |
104 | peg-ifn2a-induced | 1 |
105 | plakoglobin-expressing | 1 |
106 | podocnemidids | 1 |
107 | ponderous | 1 |
108 | pre-di | 1 |
109 | prefrontohabenular | 1 |
110 | primary/secondary/concurrent | 1 |
111 | purine-2,6,8-trione | 1 |
112 | ris/pali | 1 |
113 | sm-untreated | 1 |
114 | small-time | 1 |
115 | suction/injection | 1 |
116 | ui.review | 1 |
117 | unimpl | 1 |
118 | vegfr-3/nestin | 1 |
119 | β=0.002 | 1 |
1 | .effect | 1 |
2 | 1-lithio | 2 |
3 | 1.10/ng/ml | 1 |
4 | 1.18/ng/ml | 1 |
5 | 11,481 | 2 |
6 | 111in-labeled | 3 |
7 | 2-methylene | 1 |
8 | 230,662 | 1 |
9 | 3-deaza | 1 |
10 | 3-deaza-3-fluoroaristeromycin | 1 |
11 | 3-β-oh | 1 |
12 | 4,6,8-triaryl-quinoline-3-methanol | 1 |
13 | 48·49± | 1 |
14 | 5-arylidene | 1 |
15 | 6μg/ml | 1 |
16 | 71,000-mol | 1 |
17 | 9alpha-fluoro | 1 |
18 | aet-induced | 2 |
19 | aggression/defiant | 1 |
20 | alkoxy-substituted | 3 |
21 | all-point | 1 |
22 | alpha-and | 1 |
23 | already-approved | 1 |
24 | anastrozole-nolvadex | 1 |
25 | anthroylnitrile | 1 |
26 | audioscan | 1 |
27 | azo-metabolites | 1 |
28 | azoxy | 2 |
29 | best-published | 1 |
30 | bootstrapped | 55 |
31 | brookmeyer-crowley | 1 |
32 | burst-compensated | 2 |
33 | bu‑fei | 9 |
34 | chimaeric | 6 |
35 | chladni | 1 |
36 | conduction-band | 2 |
37 | condyles/plateaus.the | 1 |
38 | corresponding | 6,793 |
39 | corticohabenular | 2 |
40 | counterionic | 1 |
41 | cranio | 3 |
42 | cross-generalized | 1 |
43 | curlicides | 2 |
44 | deborah | 4 |
45 | delta-method.the | 1 |
46 | deuterium-bonded | 1 |
47 | diastolic-systolic | 2 |
48 | dikuiluqan | 2 |
49 | eoc-pfp | 1 |
50 | estrogen-replete | 2 |
51 | fl-based | 4 |
52 | g3a | 5 |
53 | gemfibrozil-induced | 3 |
54 | gestation-specific | 5 |
55 | gliomatoses | 1 |
56 | hanp-induced | 3 |
57 | in-transformed | 4 |
58 | intention-to-treat-based | 3 |
59 | intervention-effect | 2 |
60 | intra/intersession | 1 |
61 | iv-point | 1 |
62 | jeep | 1 |
63 | jeffreys | 1 |
64 | k_ | 1 |
65 | knoll | 2 |
66 | l6-myoblast | 2 |
67 | leukocytes/blood | 1 |
68 | levels.our | 1 |
69 | logic-insulin | 3 |
70 | low-mortality | 8 |
71 | mario | 6 |
72 | material-density | 2 |
73 | matrix-isolation | 4 |
74 | mauremys | 1 |
75 | microdosimetric | 5 |
76 | misoccupied | 1 |
77 | monobromobimane | 2 |
78 | mover-type | 1 |
79 | nma-based | 3 |
80 | non-dia | 1 |
81 | nonprenylated | 1 |
82 | o-w | 3 |
83 | others.the | 2 |
84 | peg-ifn2a-induced | 1 |
85 | phase-locked | 5 |
86 | photofragment | 2 |
87 | plakoglobin-expressing | 1 |
88 | plump | 5 |
89 | podocnemidids | 1 |
90 | ponderous | 1 |
91 | post-shodhana | 3 |
92 | pre-di | 1 |
93 | prefrontohabenular | 1 |
94 | pretitration | 5 |
95 | primary/secondary/concurrent | 1 |
96 | prodisc-ii | 2 |
97 | pt-fe₃o₄ | 3 |
98 | purine-2,6,8-trione | 1 |
99 | ramig | 2 |
100 | relative-mortality | 2 |
101 | resultant | 663 |
102 | ris/pali | 1 |
103 | sm-untreated | 1 |
104 | small-time | 1 |
105 | sonicating | 2 |
106 | stratum-specific | 11 |
107 | stretching/shrinking | 4 |
108 | substoichiometric | 6 |
109 | suction/injection | 1 |
110 | syntenic | 4 |
111 | testosterone-related | 2 |
112 | thai-specific | 3 |
113 | tongxie | 3 |
114 | trna-derived | 2 |
115 | two-substrate | 2 |
116 | ui.review | 1 |
117 | unimpl | 1 |
118 | vegfr-3/nestin | 1 |
119 | β=0.002 | 1 |
1 | 11,481 | 2 |
2 | β=0.002 | 1 |
3 | 230,662 | 1 |
4 | k_ | 1 |
5 | g3a | 5 |
6 | non-dia | 1 |
7 | post-shodhana | 3 |
8 | 3-deaza | 1 |
9 | thai-specific | 3 |
10 | stratum-specific | 11 |
11 | gestation-specific | 5 |
12 | diastolic-systolic | 2 |
13 | syntenic | 4 |
14 | counterionic | 1 |
15 | chimaeric | 6 |
16 | microdosimetric | 5 |
17 | substoichiometric | 6 |
18 | peg-ifn2a-induced | 1 |
19 | gemfibrozil-induced | 3 |
20 | hanp-induced | 3 |
21 | aet-induced | 2 |
22 | deuterium-bonded | 1 |
23 | best-published | 1 |
24 | misoccupied | 1 |
25 | phase-locked | 5 |
26 | 111in-labeled | 3 |
27 | in-transformed | 4 |
28 | bootstrapped | 55 |
29 | nma-based | 3 |
30 | fl-based | 4 |
31 | intention-to-treat-based | 3 |
32 | sm-untreated | 1 |
33 | testosterone-related | 2 |
34 | nonprenylated | 1 |
35 | burst-compensated | 2 |
36 | alkoxy-substituted | 3 |
37 | trna-derived | 2 |
38 | already-approved | 1 |
39 | cross-generalized | 1 |
40 | alpha-and | 1 |
41 | conduction-band | 2 |
42 | leukocytes/blood | 1 |
43 | delta-method.the | 1 |
44 | others.the | 2 |
45 | condyles/plateaus.the | 1 |
46 | tongxie | 3 |
47 | anthroylnitrile | 1 |
48 | small-time | 1 |
49 | monobromobimane | 2 |
50 | 5-arylidene | 1 |
51 | 2-methylene | 1 |
52 | purine-2,6,8-trione | 1 |
53 | mover-type | 1 |
54 | two-substrate | 2 |
55 | estrogen-replete | 2 |
56 | ramig | 2 |
57 | corresponding | 6,793 |
58 | stretching/shrinking | 4 |
59 | plakoglobin-expressing | 1 |
60 | sonicating | 2 |
61 | deborah | 4 |
62 | 3-β-oh | 1 |
63 | pre-di | 1 |
64 | bu‑fei | 9 |
65 | prodisc-ii | 2 |
66 | ris/pali | 1 |
67 | chladni | 1 |
68 | knoll | 2 |
69 | 1.10/ng/ml | 1 |
70 | 1.18/ng/ml | 1 |
71 | 6μg/ml | 1 |
72 | 71,000-mol | 1 |
73 | 4,6,8-triaryl-quinoline-3-methanol | 1 |
74 | unimpl | 1 |
75 | audioscan | 1 |
76 | dikuiluqan | 2 |
77 | 3-deaza-3-fluoroaristeromycin | 1 |
78 | logic-insulin | 3 |
79 | vegfr-3/nestin | 1 |
80 | intra/intersession | 1 |
81 | matrix-isolation | 4 |
82 | pretitration | 5 |
83 | suction/injection | 1 |
84 | 1-lithio | 2 |
85 | cranio | 3 |
86 | mario | 6 |
87 | 9alpha-fluoro | 1 |
88 | jeep | 1 |
89 | eoc-pfp | 1 |
90 | plump | 5 |
91 | corticohabenular | 2 |
92 | prefrontohabenular | 1 |
93 | levels.our | 1 |
94 | podocnemidids | 1 |
95 | curlicides | 2 |
96 | gliomatoses | 1 |
97 | azo-metabolites | 1 |
98 | ponderous | 1 |
99 | jeffreys | 1 |
100 | mauremys | 1 |
101 | intervention-effect | 2 |
102 | .effect | 1 |
103 | aggression/defiant | 1 |
104 | resultant | 663 |
105 | photofragment | 2 |
106 | primary/secondary/concurrent | 1 |
107 | all-point | 1 |
108 | iv-point | 1 |
109 | l6-myoblast | 2 |
110 | o-w | 3 |
111 | ui.review | 1 |
112 | anastrozole-nolvadex | 1 |
113 | brookmeyer-crowley | 1 |
114 | relative-mortality | 2 |
115 | low-mortality | 8 |
116 | material-density | 2 |
117 | azoxy | 2 |
118 | pt-fe₃o₄ | 3 |
119 | 48·49± | 1 |